1 year return (CAGR)
418.10%
Spyre Therapeutics Inc. Exchange (NASDAQ, USD)
SYRE
92.68
+1.99 (+2.80%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
159.03%
5 year return (CAGR)
-18.68%
10 year return (CAGR)
-11.15%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.30B
Price/Sales
69.58
Ent value
6.27B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 70.68 |
| Daily high | 73.51 |
| Daily low | 70.11 |
| Daily Volume | 686K |
| All-time high | 299.75 |
| 1y analyst estimate | 119.71 |
| Beta | 3.03 |
| EPS (TTM) | -2.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| SYRE | S&P500 | |
| Current price drop from All-time high | -69.08% | -1.96% |
| Highest price drop | -99.12% | -56.47% |
| Date of highest drop | 21 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -62.54% | -10.68% |
| Avg time to new high | 1268 days | 12 days |
| Max time to new high | 2534 days | 1805 days |
News
